DIFFUSE GLIOMA
Clinical trials for DIFFUSE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy shows promise for tough brain cancers
Disease control OngoingThis study tests whether two immunotherapy drugs, ipilimumab and nivolumab, can shrink or slow the growth of recurrent high-grade gliomas (brain tumors) that have a high number of genetic mutations. About 37 adults with recurrent WHO grade 4 glioma will receive these drugs. The g…
Matched conditions: DIFFUSE GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a targeted pill slow brain tumor growth after surgery?
Disease control APPROVED_FOR_MARKETINGThis expanded access program offers vorasidenib, an oral drug, to people aged 12 and older with IDH-mutated glioma who have had surgery. The drug targets specific genetic mutations in tumor cells. The goal is to see if it can help control the disease without immediate need for ra…
Matched conditions: DIFFUSE GLIOMA
Sponsor: Servier • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a common antifungal drug help fight brain cancer? new study investigates
Knowledge-focused OngoingThis early-phase trial is testing whether ketoconazole, a drug normally used for fungal infections, can get into brain tumors (gliomas) in enough amounts to possibly slow their growth. About 80 adults with different grades of glioma will take low doses of the drug before their sc…
Matched conditions: DIFFUSE GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Universitas Padjadjaran • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC